FIELD: medicine.
SUBSTANCE: invention concerns lipid content normalisation of thrombocyte membranes during metabolic syndrome (MS). For that purpose a patient undergoes 16-week therapy involving individual hypocalorific diet, graduated physical activity, administration of 40 mg lovastatin 2 times per day and of 10 mg lisinopril once in the morning.
EFFECT: reduced thrombus formation risk for the given patient group due to efficient and stable lipid content normalisation of thrombocyte membranes.
2 ex
Authors
Dates
2008-08-27—Published
2007-01-31—Filed